SUPPORTING INFORMATION
S-1 ! ! ! Figure S1 . AHLs from the control, A, and B libraries examined in this study. Compound numbering is analogous to our earlier publications. [1] Figure S2 . AHLs from the C and D libraries examined in this study. Compound numbering is analogous to our earlier publications. [1] ! Figure S3 . AHLs from the E library examined in this study. Compound numbering is analogous to our earlier publications. [2] Figure S4 . AHLs from the Q, R, and S libraries examined in this study. Compound numbering is analogous to our earlier publications. [3] ! C2  C3  C4  C5  C6  C7  C8  C9  C10  C11  C12  C13  C14  C15  C16  C17  C18  C19  C20  C21  C22  C23  C24 D2  D3  D4  D5  D6  D7  D8  D9  D10  D11  D12  D13  D15  D16  D17  D18  D19 D20 % LasR inhibition
Compound tested

PAO-JP2
PAO-JG21 E. coli JLD271
! S-9 ! Figure S9 . Primary LasR antagonism screening data for the E library in P. aeruginosa PAO-JP2 + plasILVAGFP, P. aeruginosa PAO-JG21 + plasILVAGFP, and E. coli JLD271 + pPROBE-KL. Antagonism assays were performed as described in Figure S5 . E2  E3  E4  E5  E6  E7  E8  E9  E10  E11  E12  E13  E14  E15  E16  E17  E18  E19  E20  E21  E22  E23  E24  E25  E26  E27  E28  E29  E30  E31  E32  E33  E34  E35  E36  E37  E38 E39
% LasR inhibition
Compound tested Figure S10 . Primary LasR antagonism screening data for the Q, R, and S libraries in P. aeruginosa PAO-JP2 + plasILVAGFP, P. aeruginosa PAO-JG21 + plasILVAGFP, and E. coli JLD271 + pPROBE-KL. Antagonism assays were performed as described in Figure S5 . Q2  Q3  Q4  Q5  Q6  Q7  Q8  Q9  Q10  Q11  Q12  Q13  R1  R2  R3  R4  R5  R6  R7  R8  R9  S1  S2  S3  S4  S5 S6
Compound tested All fluorescence data were background-corrected by subtracting the negative control fluorescence value (wells containing reporter strain + 2 µL DMSO only) from the experimental value. Percent (%) LasR activity was measured by normalizing the background-corrected value to the fluorescence value obtained in wells containing reporter strain + OdDHL. Percent (%) LasR inhibition = 100% -% LasR activity.
IC 50 values were calculated using GraphPad Prism. Error bars, SEM of n = 3 trials.
The % activity scale on the y-axis has been zoomed to show that LasR inhibition by DMABI, while modest, is significant relative to the negative control. 
